Late-stage Biopharmaceutical Company Granted FDA Approval For Orphan Drug Designation

Breakthrough in Combat Against Sudan Ebolavirus: FDA Grants Orphan Drug Designation to Soligenix's SuVax™.

Disclaimer: This post includes information derived from research and press releases. It is intended for educational and informational purposes only. The author/website does not have any affiliate interests, payment, or material support from the entities involved.